首页> 外文OA文献 >Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands

【2h】

Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands

机译：4-取代的哌啶和哌嗪作为平衡亲和μ阿片受体（Mor）激动剂/δOpiOID受体（DOR）拮抗剂配体的合成与评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Aaron M. Bender; Mary J. Clark; Michael P. Agius; John R. Traynor; Henry I. Mosberg;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands [J] . BenderA.M., ClarkM.J., AgiusM.P., Bioorganic and Medicinal Chemistry Letters . 2014,第2期

机译：平衡亲和力μ阿片受体（MOR）激动剂/δ阿片受体（DOR）拮抗剂配体的4-取代哌啶和哌嗪的合成与评价
2. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy mu-Opioid Receptor (MOR) Agonists/delta-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities [J] . Harland Aubrie A., Yeomans Larisa, Griggs Nicholas W., Journal of Medicinal Chemistry . 2015,第22期

机译：生物有效性，混合功效的阿片受体激动剂/δ-阿片受体激动剂的进一步优化和评估：平衡MOR和DOR亲和力
3. Opioid peptidomimetics: Leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands [J] . Mosberg H.I., Yeomans L., Harland A.A., Journal of Medicinal Chemistry . 2013,第5期

机译：阿片类肽模拟物：设计可生物利用的混合功效μ阿片受体（MOR）激动剂/δ阿片受体（DOR）拮抗剂配体的线索
4. Identification of opioid receptor ligand interactions using structurally related delta-opioid receptor agonists and antagonists and molecular modeling. [C] . Sharon D.Bryant, Yunden Jinsmaa, Lawrence H.Lazarus International Peptide Symposium;European Peptide Symposium . 2005

机译：使用结构相关的δ-阿片类受体激动剂和拮抗剂和分子建模鉴定阿片受体配体的相互作用。
5. New paradigm for drug design: Design and synthesis of novel biologically active peptides that are agonists at opioid receptors and antagonists at cholecystokinin receptors. [D] . Agnes, Richard Sario. 2003

机译：药物设计的新范例：设计和合成新型的生物活性肽，这些肽是阿片受体的激动剂，胆囊收缩素受体的拮抗剂。
6. Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity µ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands [O] . Aaron M. Bender, Mary J. Clark, Michael P. Agius, -1

机译：平衡亲和力μ阿片受体（MOR）激动剂/δ阿片受体（DOR）拮抗剂配体的4-取代哌啶和哌嗪的合成与评价
7. Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands [O] . Henry I. Mosberg, Larisa Yeomans, Aubrie A. Harland, 2013

机译：ApioID肽模拟方法：引入生物可利用的混合疗效的设计μOpioId受体（Mor）激动剂/δOpiOd受体（DOR）拮抗剂配体

Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligands

著录项

引文网络

相似文献

相关主题

期刊订阅